Pandemic Taking Its Toll On The US FDA’s Non-Pandemic Work, Alkermes CEO Says

 
• By Derrick Gingery
  
Richard Pops says the advisory committee system is broken and problems are made worse with virtual meetings.

More from US FDA Performance Tracker

More from Regulatory Trackers